Hope Family Medical Centre

Advice on HRT medication doses – new guidance 2025

High Dose Oestrogen HRT Regimes Guideline Update

This page relates to a specific change in guidance. For more information about HRT, please see: www.nhs.uk/medicines/hormone-replacement-therapy-hrt/

A recent guideline from the British Menopause Society recommends increased doses of oral or vaginal micronised progesterone (brand name Utrogestan) when used as protection against endometrial cancer in HIGH dose HRT regimes. This is because there is an increased risk of endometrial thickening, changes and cancer in those on high dose oestrogen with inadequate progesterone dosing.

Please note this guidance does NOT apply to combined oestrogen and progesterone patches or tablets.

It also does NOT apply to women who do not need progesterone because they have had a total abdominal hysterectomy.

The table below shows the levels of oestrogen that comprise different dosage regimes.

DoseUltra-LowLowStandardModerateHigh
Oestrogel½ pump1 pump2 pumps3 pumps4 pumps
Sandrena0.25mg0.5mg1mg1.5-2mg3mg
Lenzetto Spray1 spray2 sprays3 sprays4-5 sprays6 sprays
Patch12.5 mcg25mcg50mcg75mcg100mcg
Oral estradiol0.5mg1mg2mg3mg4mg

Anyone on a HIGH dose HRT regime using oral or vaginal micronized progesterone needs to be on an adequate dose, which is 200mg every night if taken continuously or 300mg for 12-14 days per month if taken sequentially. Please see table below:

Micronised ProgesteroneMedroxy progesteroneNorethisteroneLNG-IUD (52mg)
Oestrogen doseCont.Seq.Cont.Seq.Cont.Seq.Up to 5 yrs – record fitting date on script
Ultra/Low100mg200mg2.5mg10mg5mg5mg
Standard100mg200mg2.5-5mg10mg5mg5mg
Moderate100mg200mg5mg10mg5mg5mg
High200mg300mg10mg20mg5mg5mg

Please be aware that there is currently no data to show whether the increased dose of micronized progesterone will affect your breast cancer risk, however under-dosing will definitely affect your endometrial cancer risk. If you are not comfortable increasing your micronised progesterone dose you may wish to consider a Mirena coil.

People on MODERATE dose HRT regimes with oral or vaginal micronized progesterone who experience unscheduled bleeding should also be moved onto increased micronized progesterone and may need further investigation.

UNSCHEDULED BLEEDING is any bleeding on a continuous regime, or bleeding between periods on a sequential regime, that continues six months after starting HRT or three months after a dose change.  If you are experiencing unscheduled bleeding, please contact us via e-consultation directly.

Those on ULTRA-LOW/ LOW / STANDARD dose HRT regimes should also make contact via klinik if experiencing unscheduled bleeding. Otherwise please continue to complete annual HRT reviews when requested.

 

Dr Jo Parry-James    June 2025

Date published: 13th May, 2025
Date last updated: 14th May, 2025